Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | -119.32 Thousand USD | 22.02% |
| 2022 | 5.52 Million USD | 64.62% |
| 2021 | 3.35 Million USD | 427.47% |
| 2020 | 635.74 Thousand USD | 496.87% |
| 2019 | 106.51 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.02 Million USD | 205.67% |
| 2024 Q1 | 663.95 Thousand USD | -71.32% |
| 2023 Q4 | 2.31 Million USD | 38.05% |
| 2023 FY | 6.73 Million USD | 22.02% |
| 2023 Q3 | 1.67 Million USD | 28.57% |
| 2023 Q2 | 1.3 Million USD | -9.36% |
| 2023 Q1 | 1.43 Million USD | -14.31% |
| 2022 Q2 | 1.18 Million USD | -5.78% |
| 2022 Q1 | 1.26 Million USD | -12.63% |
| 2022 FY | 5.52 Million USD | 64.62% |
| 2022 Q4 | 1.67 Million USD | 20.96% |
| 2022 Q3 | 1.38 Million USD | 16.72% |
| 2021 Q1 | 225.69 Thousand USD | 16.85% |
| 2021 FY | 3.35 Million USD | 427.47% |
| 2021 Q2 | 550.45 Thousand USD | 143.89% |
| 2021 Q4 | 1.44 Million USD | 27.65% |
| 2021 Q3 | 1.13 Million USD | 105.66% |
| 2020 Q2 | 193.08 Thousand USD | -0.0% |
| 2020 FY | 635.74 Thousand USD | 496.87% |
| 2020 Q4 | 193.14 Thousand USD | 14.45% |
| 2020 Q3 | 168.76 Thousand USD | -12.59% |
| 2020 Q1 | 193.08 Thousand USD | 0.0% |
| 2019 FY | 106.51 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 100.114% |
| AngioDynamics, Inc. | 252.41 Million USD | 100.047% |
| AtriCure, Inc. | 327.05 Million USD | 100.036% |
| Avinger, Inc. | 18.63 Million USD | 100.64% |
| Azenta, Inc. | 336.26 Million USD | 100.035% |
| BioLife Solutions, Inc. | 117.57 Million USD | 100.101% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 100.007% |
| Daxor Corporation | 1.28 Million USD | 109.319% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 100.493% |
| Femasys Inc. | 15.2 Million USD | 100.785% |
| GlucoTrack, Inc. | 7.1 Million USD | 101.68% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 100.204% |
| Hologic, Inc. | 1.34 Billion USD | 100.009% |
| ICU Medical, Inc. | 717.04 Million USD | 100.017% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 100.004% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 100.457% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 100.132% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -0.0% |
| Masimo Corporation | 867 Million USD | 100.014% |
| Microbot Medical Inc. | 9.85 Million USD | 101.211% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 100.648% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 100.026% |
| Nephros, Inc. | 9.78 Million USD | 101.22% |
| NovoCure Limited | 613.92 Million USD | 100.019% |
| NEXGEL, Inc. | 4.09 Million USD | 102.913% |
| NEXGEL, Inc. | 4.09 Million USD | 102.913% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 100.117% |
| OraSure Technologies, Inc. | 125.34 Million USD | 100.095% |
| Pro-Dex, Inc. | 7.37 Million USD | 101.617% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 100.274% |
| Predictive Oncology Inc. | 15.22 Million USD | 100.784% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | 101.4% |
| QuidelOrtho Corporation | 1.35 Billion USD | 100.009% |
| Repligen Corporation | 261.12 Million USD | 100.046% |
| Sanara MedTech Inc. | 61.12 Million USD | 100.195% |
| STAAR Surgical Company | 224.55 Million USD | 100.053% |
| Sharps Technology, Inc. | 10.12 Million USD | 101.178% |
| Utah Medical Products, Inc. | 13.26 Million USD | 100.9% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 100.007% |
| Jin Medical International Ltd. | 3.91 Million USD | 103.046% |